Oscar Health, Inc. (OSCR)
NYSE: OSCR · Real-Time Price · USD
16.74
-0.26 (-1.53%)
Nov 21, 2024, 11:44 AM EST - Market open
Oscar Health Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Oscar Health stock have an average target of 22.93, with a low estimate of 13.5 and a high estimate of 28. The average target predicts an increase of 36.98% from the current stock price of 16.74.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Oscar Health stock from 7 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 5 | 5 | 5 | 4 | 4 | 4 |
| Hold | 3 | 3 | 3 | 2 | 3 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 6 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Hold → Sell Downgrades $21 → $14 | Hold → Sell | Downgrades | $21 → $14 | -19.35% | Nov 6, 2024 |
| UBS | UBS | Hold Initiates $23 | Hold | Initiates | $23 | +37.40% | Oct 7, 2024 |
| Piper Sandler | Piper Sandler | Buy Reiterates $28 | Buy | Reiterates | $28 | +67.26% | Sep 10, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $25 → $28 | Buy | Maintains | $25 → $28 | +67.26% | Aug 8, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $25 | Buy | Maintains | $25 | +49.34% | Jul 10, 2024 |
Financial Forecast
Revenue This Year
9.27B
Revenue Next Year
11.37B
from 9.27B
Increased by 22.76%
EPS This Year
0.04
from -1.22
EPS Next Year
0.61
from 0.04
Increased by 1,326.18%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 9.7B | 12.9B | 14.7B | |
| Avg | 9.3B | 11.4B | 12.8B | |
| Low | 8.8B | 10.5B | 11.3B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | - | 39.3% | 29.0% | |
| Avg | - | 22.8% | 12.5% | |
| Low | - | 13.2% | -0.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 0.12 | 0.95 | 1.48 | |
| Avg | 0.04 | 0.61 | 1.26 | |
| Low | -0.05 | 0.39 | 1.01 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | - | 2,123.4% | 144.2% | |
| Avg | - | 1,326.2% | 108.7% | |
| Low | - | 822.3% | 66.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.